Model Informed Drug Development Archives

Case Study

Accelerated ADC Approval Through Expert Modeling and Data Rescue

See how Certara rescued complex ADC PK datasets, delivered PopPK, exposure-response modeling, and enabled rapid…

Certara2025 年 12 月 15 日

Case Study

Merck Advances Pediatric Oncology with Innovative ADC Modeling

Merck leveraged ADC modeling and pediatric ADC dose optimization to enable FDA acceptance and advance…

Certara2025 年 12 月 12 日

Conference

ICoP 2026 India

Danielle Pillsbury2025 年 12 月 11 日

Fact Sheet

Expedited Pharmacometrics Regulatory Submissions

Certara delivers complete, compliant pharmacometric regulatory submission packages in just 4–6 weeks, eliminating the PMx…

Certara2025 年 12 月 8 日

Announcement

Certara Cuts Pharmacometrics Submission Timelines in Half: New Expedited Service Accelerates Global Regulatory Filings

Certara launches an expedited Pharmacometrics (PMx) Regulatory Submission service that cuts submission timelines in half.

Certara2025 年 12 月 3 日

Publication

History and Evolution of Innovations in Clinical Pharmacology

This paper reviews how decades of scientific and technological advances have transformed clinical pharmacology and…

Danielle Pillsbury2025 年 11 月 26 日

Publication

Modeling amyloid plaque turnover dynamics improves characterization of drug effects

Researchers modeled how amyloid plaques form and clear in Alzheimer’s disease, helping explain how treatments…

Certara2025 年 11 月 26 日

Guide

10 Strategic Foundations for Early Drug Development

Discover effective Early Drug Development strategies to navigate early development with confidence and clarity. Download…

Certara2025 年 11 月 26 日

Publication

Physiologically-Based Pharmacokinetic Modeling to Support Pediatric Clinical Development: An IQ Working Group Perspective on the Current Status and Challenges

The paper reviews current applications of pediatric PBPK across therapeutic areas and outlines where PBPK…

Certara2025 年 11 月 21 日

Guide

A Guide to the FDA Announcement to Phase Out Animal Testing for Drugs

The FDA is phasing out animal testing of new drugs. Learn how Certara’s Non-Animal Navigator™…

Certara2025 年 11 月 17 日

模型引导的药物开发

Accelerated ADC Approval Through Expert Modeling and Data Rescue

Merck Advances Pediatric Oncology with Innovative ADC Modeling

ICoP 2026 India

Expedited Pharmacometrics Regulatory Submissions

Certara Cuts Pharmacometrics Submission Timelines in Half: New Expedited Service Accelerates Global Regulatory Filings

History and Evolution of Innovations in Clinical Pharmacology

Modeling amyloid plaque turnover dynamics improves characterization of drug effects

10 Strategic Foundations for Early Drug Development

Physiologically-Based Pharmacokinetic Modeling to Support Pediatric Clinical Development: An IQ Working Group Perspective on the Current Status and Challenges

A Guide to the FDA Announcement to Phase Out Animal Testing for Drugs

订阅时事通讯

快捷链接

解决方案

联系我们